Home
Clinical Trials
Measuring Consequences of Dis...

Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

233 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-10-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to measure economic burden of Multiple Sclerosis (MS) from a new point of view that includes consequences of disability on Quality Of Life (QOL), social participation and capabilities of patients and caregivers. To the investigators' knowledge, there is currently no data including intangible costs related to caregivers and calculating the overall economic cost of Multiple Sclerosis, particularly, in France.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Multiple Sclerosis From the Viewpoint of the Caregivers

NCT02388334

Multiple Sclerosis

UNKNOWN

Characterization of Cortical Injury in Early MS Patients: a 7T MRI Study

NCT03624296

Multiple Sclerosis (MS)

UNKNOWN NA

Study of Empathy in MS

NCT05332951

Multiple Sclerosis

COMPLETED

Therapeutic Adherence of Multiple Sclerosis Patients

NCT04837352

Multiple Sclerosis

RECRUITING

Disability, Perceived Social Support and Quality of Life in Multiple Sclerosis

NCT02880553

Multiple Sclerosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this study is to evaluate prospectively the economic burden of Multiple Sclerosis (MS) in France by calculating direct costs (medical and non-medical) and indirect costs and by estimating consequences of MS on utility (QALY) of patients and caregivers in a societal perspective.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis Physical Disability Economic Burden Social Interaction Capability Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant aged 18 or more
* Confirmed MS diagnosis (McDonald 2005)
* Defined type of MS according classification of Lublin and Reingold

Exclusion Criteria

* Subject living in an institution
* Severe cognitive dysfunction preventing to answer questionnaire
* Subject already included in other clinical study (phase 1 to 3)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers